drug
(donepezil hydrochloride + memantine hydrochloride ER)
Marketedupdated 3mo agoby $ABBV AbbVie Inc.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 24, 2029
~2.6 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (12)
- Dec 5, 2029method-of-use (U-1641)US 80582913.3y
- Dec 5, 2029method-of-use (U-1641)US 80582913.3y
- Dec 5, 2029method-of-use (U-1641)US 80582913.3y
- Dec 5, 2029method-of-use (U-1641)US 80582913.3y
- Sep 24, 2029patentUS 8039009*PED3.1y
- Sep 24, 2029patentUS 8039009*PED3.1y
- Sep 24, 2029patentUS 8039009*PED3.1y
- Sep 24, 2029patentUS 8039009*PED3.1y
- Mar 24, 2029method-of-use (U-1641)US 80390092.6y
- Mar 24, 2029method-of-use (U-1641)US 80390092.6y
- Mar 24, 2029method-of-use (U-1641)US 80390092.6y
- Mar 24, 2029method-of-use (U-1641)US 80390092.6y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 26m ago
Found something off?
comments(0)
5-min edit window · permanent after that